These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11262375)

  • 1. [Infection and atherosclerosis].
    Gurfinkel EP
    Rev Esp Cardiol; 2001 Mar; 54(3):383-92. PubMed ID: 11262375
    [No Abstract]   [Full Text] [Related]  

  • 2. Infection, endothelial dysfunction, and atherogenesis.
    Kaski JC
    Circulation; 2003 Dec; 108(25):E171-2; author reply E171-2. PubMed ID: 14691029
    [No Abstract]   [Full Text] [Related]  

  • 3. Insights into the role of infection in atherogenesis and in plaque rupture.
    Epstein SE; Zhu J; Najafi AH; Burnett MS
    Circulation; 2009 Jun; 119(24):3133-41. PubMed ID: 19546396
    [No Abstract]   [Full Text] [Related]  

  • 4. Association between eotaxin (CCL11), C-reactive protein, and antimicrobial antibodies in patients undergoing coronary angioplasty.
    Kaehler J; Tuleweit A; Steven D; Krempl T; Haar A; Carstensen M; Koester R; Terres W; Meinertz T
    J Investig Med; 2006 Dec; 54(8):446-54. PubMed ID: 17169268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Accelerated coronary atherosclerosis of the transplanted heart].
    Cuny C; Eicher JC; Morvan Y; Wolf JE; Louis P
    Ann Med Interne (Paris); 1993; 144(6):419-24. PubMed ID: 8122825
    [No Abstract]   [Full Text] [Related]  

  • 6. The ten most commonly asked questions about infection as a cause of atherosclerotic heart disease.
    Muhlestein JB
    Cardiol Rev; 1999; 7(5):251-3. PubMed ID: 11208234
    [No Abstract]   [Full Text] [Related]  

  • 7. Interactive role of infection, inflammation and traditional risk factors in atherosclerosis and coronary artery disease.
    Mehta JL; Saldeen TG; Rand K
    J Am Coll Cardiol; 1998 May; 31(6):1217-25. PubMed ID: 9581711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of inflammation and infection in coronary artery disease.
    Becker AE; de Boer OJ; van Der Wal AC
    Annu Rev Med; 2001; 52():289-97. PubMed ID: 11160780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunology. Targeting the tolls.
    Wickelgren I
    Science; 2006 Apr; 312(5771):184-7. PubMed ID: 16614188
    [No Abstract]   [Full Text] [Related]  

  • 10. Inflammation, infection, or both in atherosclerosis: the ROXIS trial in perspective.
    Gurfinkel E
    J Infect Dis; 2000 Jun; 181 Suppl 3():S566-8. PubMed ID: 10839760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cardiovascular pharmacology (XII). Pharmacologic interventions in the progression of coronary atherosclerosis].
    Rayo Llerena I; Marín Huerta E
    Rev Esp Cardiol; 1995 May; 48(5):341-58. PubMed ID: 7792429
    [No Abstract]   [Full Text] [Related]  

  • 12. Influenza, autoimmunity and atherogenesis.
    Gurevich VS
    Autoimmun Rev; 2005 Feb; 4(2):101-5. PubMed ID: 15722256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experimental development of atherosclerosis].
    Fomenko DV; Zoloeva PV; Mikhaĭlova NN; Safina VP
    Med Tr Prom Ekol; 2006; (6):28-30. PubMed ID: 16898247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmune nature of influenza atherogenicity.
    Gurevich VS; Pleskov VM; Levaya MV
    Ann N Y Acad Sci; 2005 Jun; 1050():410-6. PubMed ID: 16014558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of metabolic syndrome versus infectious burden on inflammation, severity of coronary atherosclerosis, and major adverse cardiovascular events.
    Dai DF; Lin JW; Kao JH; Hsu CN; Chiang FT; Lin JL; Chou YH; Hsu KL; Tseng CD; Tseng YZ; Hwang JJ
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2532-7. PubMed ID: 17426096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronary and peripheral artery atherosclerosis: what choice for antiplatelet therapy.
    Gresele P
    J Cardiovasc Med (Hagerstown); 2018 Feb; 19 Suppl 1():e72-e74. PubMed ID: 29538147
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of ACE inhibitors on coronary atherosclerosis and restenosis.
    Timmis AD; Pitt B
    Br Heart J; 1994 Sep; 72(3 Suppl):S57-60. PubMed ID: 7946805
    [No Abstract]   [Full Text] [Related]  

  • 18. Mechanisms of benefit of angiotensin receptor blockers in coronary atherosclerosis.
    Vaccari CS; Lerakis S; Hammoud R; Khan BV
    Am J Med Sci; 2008 Sep; 336(3):270-7. PubMed ID: 18794623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic infection and coronary artery disease.
    Muhlestein JB
    Med Clin North Am; 2000 Jan; 84(1):123-48. PubMed ID: 10685131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ongoing debate over the association between Chlamydia pneumoniae infection and coronary artery disease: antibiotic dilemma.
    Celik T; Iyisoy A; Celik M; Isik E
    Int J Cardiol; 2008 Nov; 130(2):260-1; author reply 262-3. PubMed ID: 17662493
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.